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The deposition of amyloid in the heart valves is a well-known occurrence in generalised primary amyloidosis and in senile cardiac amyloidosis. A survey of the literature concerning cardiac localisations of amyloidosis shows that valvular involvement is a relatively infrequent finding (Silwer and Lindblom, 1926; Lubarsch, 1929; Koller, 1932; Israel, 1933; Kerwin, 1936; Koletsky and Stecher, 1939; Dillon and Evans, 1942; Lindsay and Knorp, 1945; Lindsay, 1946; Ranstrom, 1946; Dahlin, 1949; Dahlin and Edwards, 1949; Ballinger, 1949; Hulbert and Meyer, 1949; Jones and Frazier, 1950; Woolf, 1950; Symmers, 1956a/b; Benson and Smith, 1956; Frederiksen et al., 1962; Pomerance, 1966; Buja et al., 1970) . This may explain why, although amyloidosis of the heart muscle was already known by 1857 (Virchow, 1857) , valvular amyloidosis had to wait until 1922 to be reported in a case of what now appears to have been the senile form of cardiac amyloidosis (Kann, 1922) .
The structures mainly affected by cardiac amyloidosis are the blood vessels and the myocardium, particularly in the interauricular septum and in the ventricular wall (Pomerance, 1966; Buja, et al., 1970) . Where valvular deposits are present, they may be found in one or more valves, the mitral and tricuspid being the most frequently involved. Other noteworthy features of this classical type of valvular amyloidosis are that the deposits occur in previously unaltered valves and that in senile cases they apparently develop as a consequence of an age-related degenerative disorder of the connective tissue.
Received for publication 28 June 1979 The purpose of the present paper is to report another type of valvular amyloidosis which appears in relation to local scarring. It was discovered accidentally by histological examination of chronically diseased heart valves which had been surgically removed for valvular stenosis and/or incompetence. Subsequently we extended our investigation in order to include adequate controls which were taken from necropsy material.
Material and methods
A total of 226 surgically removed heart valves were examined. The final diagnoses, based on the histological lesions and the clinical data were: healed process of chronic or recurrent rheumatic disease, subacute or healed bacterial endocarditis, congenital malformation, sclerotic age-related degeneration. and mucoid degeneration. In 56 cases the exact nature of the valvulopathy could not be determined (Table 1) .
Controls consisted of a total of 147 heart valves removed at necropsy from patients who had died from various causes, valvulopathies being excluded. Statistically, no correlation could be established between the occurrence of valvular amyloidosis and the age of the patient (chi square) (Fig. 4) Schwartz (1976) , amyloid deposits may develop from scar hyalin and from fibrin. This form of valvular amyloidosis appears to be a good example of such a transformation. By comparison with the analogous situation existing in respect to pathological calcification we propose to designate this particular form of valvular amyloidosis dystrophic.
By contrast, when 147 heart valves removed at necropsy from patients who had no overt valvular disease were examined histologically, amyloidosis was discovered in only one case, that of a 66-year-old man with typical senile amyloidosis of the heart. In this instance, however, the deposits were quite dissimilar from those observed in the surgical specimens. They were so extensive as to be apparent to naked-eye examination; they furthermore produced verrucous elevations which correspond to their superficial localisation in the valve tissues. The findings in our control group accord with the general experience (Kann, 1922; Silwer and Lindblom, 1926; Lubarsch, 1929; Koller, 1932; Israel, 1933; Kerwin, 1936; Koletsky and Stecher, 1939; Dillon and Evans, 1942; Lindsay and Knorp, 1945; Lindsay, 1946; Ranstrbm, 1946; Dahlin 1949; Ballinger, 1949; Hulbert and Meyer, 1949; Jones and Frazier, 1950; Woolf, 1950; Symmers 1956b; Benson and Smith, 1956) : previously unaltered valves are not frequently the seat of amyloid, and when they are involved, as may happen in generalised amyloidosis or in localised senile heart amyloidosis, the deposits are quite unlike those seen in severe damaged valves.
Dystrophic amyloidosis of the heart valves thus appears as a unique type of alteration. It has hitherto seemingly escaped recognition, presumably because of the smallness of the deposits and their easy confusion with foci of hyalinised connective tissue. The well-known difficulty of identifying amyloid with certainty must also be taken into account. We used as a criterion the green dichroism imparted by Congo red under polarised light, a reaction that is generally accepted as the most reliable and sensitive test for amyloid. In addition, in one case, which is not included in this series, electron microscopy was performed on the heavily calcified bicuspid aortic valve of a 54-year-old individual. Examination of iodine and Congo red positive areas confirmed the presence of microfibrils with ultrastructural features specific for amyloid (Shirahama and Cohen, 1967) (Fig. 5) Westermark et al. (1977) have recently established the presence of a specific protein subunit. A point that deserves further consideration is whether dystrophic amyloidosis could affect structures other than the heart valves. The question arises for atheromatous lesions, whether situated at the base of the heart valve as was observed in one of our surgical specimens or in the aortae as was described by Wright et al. (1969) . These authors were, however, unable to demonstrate any significant relationship between the presence of amyloid and the degree of atherosclerosis.
With regard to the pathogenesis of this condition, one can only speculate as to the respective roles of three possible factors: (a) the presence in the circulating plasma of amyloid precursors; (b) an increased permeability of the damaged valvular surface; and (c) the local appearance, within the altered ground substance of the valvular connective tissue, of abnormal substances with a strong capacity to bind the amyloid precursors, which have premeated this tissue.
